The CNS/PNS Extracellular Matrix Provides Instructive Guidance Cues to Neural Cells and Neuroregulatory Proteins in Neural Development and Repair
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Early Acute Microvascular Kidney Transplant Rejection in The
CLINICAL RESEARCH www.jasn.org Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens Marianne Delville,1,2,3 Baptiste Lamarthée,4 Sylvain Pagie,5,6 Sarah B. See ,7 Marion Rabant,3,8 Carole Burger,3 Philippe Gatault ,9,10 Magali Giral,11 Olivier Thaunat,12,13,14 Nadia Arzouk,15 Alexandre Hertig,16,17 Marc Hazzan,18,19,20 Marie Matignon,21,22,23 Christophe Mariat,24,25 Sophie Caillard,26,27 Nassim Kamar,28,29 Johnny Sayegh,30,31 Pierre-François Westeel,32 Cyril Garrouste,33 Marc Ladrière,34 Vincent Vuiblet,35 Joseph Rivalan,36 Pierre Merville,37,38,39 Dominique Bertrand,40 Alain Le Moine,41,42 Jean Paul Duong Van Huyen,3,8 Anne Cesbron,43 Nicolas Cagnard,3,44 Olivier Alibeu,3,45 Simon C. Satchell,46 Christophe Legendre,3,4,47 Emmanuel Zorn,7 Jean-Luc Taupin,48,49,50 Béatrice Charreau,5,6 and Dany Anglicheau 3,4,47 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background Although anti-HLA antibodies (Abs) cause most antibody-mediated rejections of renal allo- grafts, non-anti–HLA Abs have also been postulated to contribute. A better understanding of such Abs in rejection is needed. Methods We conducted a nationwide study to identify kidney transplant recipients without anti-HLA donor-specific Abs who experienced acute graft dysfunction within 3 months after transplantation and showed evidence of microvascular injury, called acute microvascular rejection (AMVR). -
Human FGFBP1 ELISA Kit (ARG82056)
Product datasheet [email protected] ARG82056 Package: 96 wells Human FGFBP1 ELISA Kit Store at: 4°C Summary Product Description Human FGFBP1 ELISA Kit is an Enzyme Immunoassay kit for the quantification of Human FGFBP1 in serum, plasma and cell culture supernatants. Tested Reactivity Hu Tested Application ELISA Target Name FGFBP1 Conjugation HRP Conjugation Note Substrate: TMB and read at 450 nm. Sensitivity 11.7 pg/ml Sample Type Serum, plasma and cell culture supernatants. Standard Range 23.4 - 1500 pg/ml Sample Volume 100 µl Alternate Names Fibroblast growth factor-binding protein 1; 17 kDa heparin-binding growth factor-binding protein; FGF- BP; FGF-binding protein 1; HBp17; FGFBP; 17 kDa HBGF-binding protein; FGFBP-1; HBP17; FGF-BP1 Application Instructions Assay Time 4.5 hours Properties Form 96 well Storage instruction Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol FGFBP1 Gene Full Name fibroblast growth factor binding protein 1 Background This gene encodes a secreted fibroblast growth factor carrier protein. The encoded protein plays a critical role in cell proliferation, differentiation and migration by binding to fibroblast growth factors and potentiating their biological effects on target cells. The encoded protein may also play a role in tumor growth as an angiogenic switch molecule, and expression of this gene has been associated with several types of cancer including pancreatic and colorectal adenocarcinoma. -
Supervised Group Lasso with Applications to Microarray Data Analysis
SUPERVISED GROUP LASSO WITH APPLICATIONS TO MICROARRAY DATA ANALYSIS Shuangge Ma1, Xiao Song2, and Jian Huang3 1Department of Epidemiology and Public Health, Yale University 2Department of Health Administration, Biostatistics and Epidemiology, University of Georgia 3Departments of Statistics and Actuarial Science, and Biostatistics, University of Iowa March 2007 The University of Iowa Department of Statistics and Actuarial Science Technical Report No. 375 1 Supervised group Lasso with applications to microarray data analysis Shuangge Ma¤1 Xiao Song 2and Jian Huang 3 1 Department of Epidemiology and Public Health, Yale University, New Haven, CT 06520, USA 2 Department of Health Administration, Biostatistics and Epidemiology, University of Georgia, Athens, GA 30602, USA 3 Department of Statistics and Actuarial Science, University of Iowa, Iowa City, IA 52242, USA Email: Shuangge Ma¤- [email protected]; Xiao Song - [email protected]; Jian Huang - [email protected]; ¤Corresponding author Abstract Background: A tremendous amount of e®orts have been devoted to identifying genes for diagnosis and prognosis of diseases using microarray gene expression data. It has been demonstrated that gene expression data have cluster structure, where the clusters consist of co-regulated genes which tend to have coordinated functions. However, most available statistical methods for gene selection do not take into consideration the cluster structure. Results: We propose a supervised group Lasso approach that takes into account the cluster structure in gene expression data for gene selection and predictive model building. For gene expression data without biological cluster information, we ¯rst divide genes into clusters using the K-means approach and determine the optimal number of clusters using the Gap method. -
Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: a Systematic Review
cells Systematic Review Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: A Systematic Review Efpraxia Kritikaki 1, Rhiannon Asterling 1, Lesley Ward 1 , Kay Padget 1, Esther Barreiro 2 and Davina C. M. Simoes 1,* 1 Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne NE1 8ST, UK; effi[email protected] (E.K.); [email protected] (R.A.); [email protected] (L.W.); [email protected] (K.P.) 2 Pulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), CIBERES, 08002 Barcelona, Spain; [email protected] * Correspondence: [email protected] Abstract: Exercise training promotes muscle adaptation and remodelling by balancing the processes of anabolism and catabolism; however, the mechanisms by which exercise delays accelerated muscle wasting are not fully understood. Intramuscular extracellular matrix (ECM) proteins are essential to tissue structure and function, as they create a responsive environment for the survival and repair of the muscle fibres. However, their role in muscle adaptation is underappreciated and underinvesti- gated. The PubMed, COCHRANE, Scopus and CIHNAL databases were systematically searched from inception until February 2021. The inclusion criteria were on ECM adaptation after exercise training in healthy adult population. Evidence from 21 studies on 402 participants demonstrates that exercise training induces muscle remodelling, and this is accompanied by ECM adaptation. All types Citation: Kritikaki, E.; Asterling, R.; of exercise interventions promoted a widespread increase in collagens, glycoproteins and proteo- Ward, L.; Padget, K.; Barreiro, E.; C. -
Perlecan Antagonizes Collagen IV and ADAMTS9/GON-1 in Restricting the Growth of Presynaptic Boutons
The Journal of Neuroscience, July 30, 2014 • 34(31):10311–10324 • 10311 Development/Plasticity/Repair Perlecan Antagonizes Collagen IV and ADAMTS9/GON-1 in Restricting the Growth of Presynaptic Boutons Jianzhen Qin,1,2 Jingjing Liang,1 and X Mei Ding1 1State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China, and 2University of Chinese Academy of Sciences, Beijing 100049, China In the mature nervous system, a significant fraction of synapses are structurally stable over a long time scale. However, the mechanisms that restrict synaptic growth within a confined region are poorly understood. Here, we identified that in the C. elegans neuromuscular junction, collagens Type IV and XVIII, and the secreted metalloprotease ADAMTS/GON-1 are critical for growth restriction of presyn- apticboutons.Withoutthesecomponents,ectopicboutonsprogressivelyinvadeintothenonsynapticregion.Perlecan/UNC-52promotes the growth of ectopic boutons and functions antagonistically to collagen Type IV and GON-1 but not to collagen XVIII. The growth constraint of presynaptic boutons correlates with the integrity of the extracellular matrix basal lamina or basement membrane (BM), which surrounds chemical synapses. Fragmented BM appears in the region where ectopic boutons emerge. Further removal of UNC-52 improves the BM integrity and the tight association between BM and presynaptic boutons. Together, our results unravel the complex role of the BM in restricting the growth of presynaptic boutons and reveal the antagonistic function of perlecan on Type IV collagen and ADAMTS protein. Key words: ADAMTS9/GON-1; basement membrane; perlecan/UNC-52; presynaptic boutons; Type IV collagen/EMB-9; Type XVIII collagen/CLE-1 Introduction wider and present in the form of a basal lamina or basement Synapses are specialized intercellular junctions between neu- membrane (BM) (Palay and Chan-Palay, 1976; Burns and Au- rons or between neurons and other excitable cells. -
Retinal Pigment Epithelium Protein of 65 Kda Gene
Molecular Vision 2013; 19:2312-2320 <http://www.molvis.org/molvis/v19/2312> © 2013 Molecular Vision Received 31 July 2013 | Accepted 14 November 2013 | Published 16 November 2013 Retinal pigment epithelium protein of 65 kDA gene-linked retinal degeneration is not modulated by chicken acidic leucine-rich epidermal growth factor-like domain containing brain protein/ Neuroglycan C/ chondroitin sulfate proteoglycan 5 Sandra Cottet,1,2 René Jüttner,3 Nathalie Voirol,1 Pierre Chambon,4 Fritz G. Rathjen,3 Daniel F. Schorderet,1,2,5 Pascal Escher1,2 1Institute for Research in Ophthalmology, Sion, Switzerland; 2Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland; 3Max-Delbrück-Centrum, Berlin, Germany; 4Institut de Génétique et de Biologie Moléculaire et Cellulaire, Collège de France, Strasbourg, France; 5EPFL-Ecole Polytechnique Fédérale, Lausanne, Switzerland Purpose: To analyze in vivo the function of chicken acidic leucine-rich epidermal growth factor-like domain containing brain protein/Neuroglycan C (gene symbol: Cspg5) during retinal degeneration in the Rpe65−/− mouse model of Leber congenital amaurosis. Methods: We resorted to mice with targeted deletions in the Cspg5 and retinal pigment epithelium protein of 65 kDa (Rpe65) genes (Cspg5−/−/Rpe65−/−). Cone degeneration was assessed with cone-specific peanut agglutinin staining. Tran- scriptional expression of rhodopsin (Rho), S-opsin (Opn1sw), M-opsin (Opn1mw), rod transducin α subunit (Gnat1), and cone transducin α subunit (Gnat2) genes was assessed with quantitative PCR from 2 weeks to 12 months. The retinal pigment epithelium (RPE) was analyzed at P14 with immunodetection of the retinol-binding protein membrane receptor Stra6. Results: No differences in the progression of retinal degeneration were observed between the Rpe65−/− and Cspg5−/−/ Rpe65−/− mice. -
Extracellular Matrix Composition of Connective Tissues: Systematic Review and Meta- Analysis
1 Extracellular matrix composition of connective tissues: systematic review and meta- analysis Turney McKee, Dentistry Division of Biomedical Sciences, McGill University, Montreal Submitted April, 2018 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science © Turney McKee 2018 2 Table of Contents Abstract • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 3 Acknowledgements • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 6 Contribution of Authors • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 6 Introduction and Objectives • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 7 Review of the Literature Connective tissue, general introduction • • • • • • • • • • • • • • • • • • • • • • • 9 Extracellular matrix and its components • • • • • • • • • • • • • • • • • • • • • • 9 ECM remodeling and structural requirements • • • • • • • • • • • • • • • • • • 12 Adipose tissue • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 13 Tendon and ligament • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •14 Bone • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 15 Articular Cartilage • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 15 IVD • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 17 Relevance and importance of proteomic composition • • • • • • • • • • • • • • • 18 Methods -
3D Distribution of Perlecan Within Intervertebral Disc Chondrons Suggests Novel Regulatory Roles for This Multifunctional Modular Heparan Sulphate Proteoglycan A.J
EuropeanAJ Hayes etCells al. and Materials Vol. 41 2021 (pages 73-89) DOI: 10.22203/eCM.v041a06 Nuclear and cytoplasmic localisation ISSN of1473-2262 perlecan 3D DISTRIBUTION OF PERLECAN WITHIN INTERVERTEBRAL DISC CHONDRONS SUGGESTS NOVEL REGULATORY ROLES FOR THIS MULTIFUNCTIONAL MODULAR HEPARAN SULPHATE PROTEOGLYCAN A.J. Hayes1 and J. Melrose2,3,4,* 1 Bioimaging Research Hub, Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, Wales, UK 2 Graduate School of Biomedical Engineering, UNSW Sydney, Sydney, NSW 2052, Australia 3 Raymond Purves Bone and Joint Research Laboratories, Kolling Institute of Medical Research, Royal North Shore Hospital and The Faculty of Medicine and Health, The University of Sydney, St. Leonards, NSW 2065, Australia 4 Sydney Medical School, Northern, Sydney University, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia Abstract Perlecan is a modular, multifunctional heparan sulphate-proteoglycan (HS-PG) that is present in the pericellular and wider extracellular matrix of connective tissues. In the present study, confocal microscopy was used to study perlecan distribution within intervertebral disc chondrons. Perlecan immunolabel was demonstrated intracellularly and in close association with the cell nucleus within chondrons of both the annulus fibrosus (AF) and nucleus pulposus (NP). This observation is consistent with earlier studies that have localised HS-PGs with nuclear cytoskeletal components. Nuclear HS-PGs have been proposed to transport fibroblast growth factor (FGF)-1, FGF-2 and FGFR-1 into the cell nucleus, influencing cell proliferation and the cell-cycle. Perlecan has well-known interactive properties with FGF family members in the pericellular and extracellular matrix. Perinuclear perlecan may also participate in translocation events with FGFs. -
Discovery of Resistance Pathways to Fibroblast Growth Factor Receptor Inhibition in Bladder Cancer
bioRxiv preprint doi: https://doi.org/10.1101/183293; this version posted August 31, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Discovery of Resistance Pathways to Fibroblast Growth Factor Receptor inhibition in Bladder Cancer Sumanta K Pal, Miaoling He, Jeremy O Jones Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA Running Title: FGFRi resistance in bladder cancer Corresponding Author and to whom reprint requests should be made: Jeremy Jones 1500 E Duarte Rd Beckman 2310 Duarte, CA 91010 Phone: 626-256-4673 ext 80270 Fax: 626-471-3902 Email: [email protected] Figures: 4 Total Words (Abstract Words): 3438 (218) bioRxiv preprint doi: https://doi.org/10.1101/183293; this version posted August 31, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract: Background: Aberrant fibroblast growth factor receptor (FGFR) signaling drives the growth of many bladder cancers. NVP-BGJ398 is a small molecule with potent inhibitory activity of FGFRs 1, 2, and 3, and has been shown to selectively inhibit the growth of bladder cancer cell lines that over-express FGFR3 or have oncogenic FGFR3 fusions. As with many agents targeting receptor tyrosine kinases, resistance is known to develop. Objective: We sought to identify potential mechanisms of resistance to NVP-BGJ398 in cell culture models of bladder cancer. Methods: RT-112 bladder cancer cell lines were derived that were resistant to growth in 3uM NVP-BGJ398. -
A Model for Profiling the Emolecular Effects of Alcohol
The Pharmacogenomics Journal (2015) 15, 177–188 © 2015 Macmillan Publishers Limited All rights reserved 1470-269X/15 www.nature.com/tpj ORIGINAL ARTICLE The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol D Most1,2, L Ferguson1,2, Y Blednov1, RD Mayfield1 and RA Harris1 Chronic alcohol consumption changes gene expression, likely causing persistent remodeling of synaptic structures via altered translation of mRNAs within synaptic compartments of the cell. We profiled the transcriptome from synaptoneurosomes (SNs) and paired total homogenates (THs) from mouse amygdala following chronic voluntary alcohol consumption. In SN, both the number of alcohol-responsive mRNAs and the magnitude of fold-change were greater than in THs, including many GABA-related mRNAs upregulated in SNs. Furthermore, SN gene co-expression analysis revealed a highly connected network, demonstrating coordinated patterns of gene expression and highlighting alcohol-responsive biological pathways, such as long-term potentiation, long-term depression, glutamate signaling, RNA processing and upregulation of alcohol-responsive genes within neuroimmune modules. Alterations in these pathways have also been observed in the amygdala of human alcoholics. SNs offer an ideal model for detecting intricate networks of coordinated synaptic gene expression and may provide a unique system for investigating therapeutic targets for the treatment of alcoholism. The Pharmacogenomics Journal (2015) 15, 177–188; doi:10.1038/tpj.2014.43; published online 19 August 2014 INTRODUCTION mRNAs from SN15,16,18,19 and TH samples from mouse amygdala, a Alcohol dependence is a severe and widespread disease. Over 17 brain region known to be involved with the negative reinforce- 20 million Americans suffer from alcohol-related problems; total cost ment of alcohol and other drugs of abuse. -
Anti-FGFBP1 Antibody (ARG41185)
Product datasheet [email protected] ARG41185 Package: 100 μl anti-FGFBP1 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes FGFBP1 Tested Reactivity Hu, Ms, Rat Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name FGFBP1 Antigen Species Human Immunogen Recombinant fusion protein corresponding to aa. 24-234 of Human FGFBP1 (NP_005121.1). Conjugation Un-conjugated Alternate Names Fibroblast growth factor-binding protein 1; 17 kDa heparin-binding growth factor-binding protein; FGF- BP; FGF-binding protein 1; HBp17; FGFBP; 17 kDa HBGF-binding protein; FGFBP-1; HBP17; FGF-BP1 Application Instructions Application table Application Dilution WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control A549 Calculated Mw 26 kDa Observed Size 30 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol FGFBP1 Gene Full Name fibroblast growth factor binding protein 1 Background This gene encodes a secreted fibroblast growth factor carrier protein. -
Multiple Antibodies Identify Glypican-1 Associated with Exosomes from Pancreatic
bioRxiv preprint doi: https://doi.org/10.1101/145706; this version posted July 6, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Multiple antibodies identify glypican-1 associated with exosomes from pancreatic cancer cells and serum from patients with pancreatic cancer Chengyan Dong1*, Li Huang1*, Sonia A. Melo2,3,4, Paul Kurywchak1, Qian Peng1, Christoph Kahlert5, Valerie LeBleu1# & Raghu Kalluri1# 1Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77005 2Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal (iI3S), 4200 Porto, Portugal; 3Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP), 4200 Porto, Portugal; 4Medical School, Porto University (FMUP), 4200 Porto, Portugal 5 Department of Gastrointestinal, Thoracic and Vascular Surgery, Technische Universität Dresden, Germany * co-first authors # co-corresponding authors Exosomes are man-sized vesicles shed by all cells, including cancer cells. Exosomes can serve as novel liquid biopsies for diagnosis of cancer with potential prognostic value. The exact mechanism/s associated with sorting or enrichment of cellular components into exosomes are still largely unknown. We reported Glypican-1 (GPC1) on the surface of cancer exosomes and provided evidence for the enrichment of GPC1 in exosomes from patients with pancreatic cancer1. Several different laboratories have validated this novel conceptual advance and reproduced the original experiments using multiple antibodies from different sources. These include anti-GPC1 antibodies from ThermoFisher (PA5- 28055 and PA-5-24972)1,2, Sigma (SAB270028), Abnova (MAB8351, monoclonal antibodies clone E9E)3, EMD Millipore (MAB2600-monoclonal antibodies)4, SantaCruz5, and R&D Systems (BAF4519)2.